Concentration of meropenem in patients with sepsis and acute kidney injury before and after initiation of continuous renal replacement therapy: a prospective observational trial

β-lactam dosage regimens in septic patients with augmented renal clearance

(2018) Alexandra Jacobs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials

(2018) Konstantinos Z Vardakas et al.   LANCET INFECTIOUS DISEASES

OUP accepted manuscript

(2018)   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose

(2018) Tatsuro Tamatsukuri et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models

(2018) Sofie A M Dhaese et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

(2017) Andrew Rhodes et al.   INTENSIVE CARE MEDICINE

Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy

(2017) Caleb J.P. Economou et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing

(2016) Nikolas J. Onufrak et al.   CLINICAL THERAPEUTICS

We Underdose Antibiotics in Patients on CRRT

(2016) Alexander R. Shaw et al.   SEMINARS IN DIALYSIS

Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem during the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units

(2015) Sutep Jaruratanasirikul et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?

(2015) Janattul-Ain Jamal et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration

(2015) Janattul-Ain Jamal et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents

(2014) Stijn I. Blot et al.   ADVANCED DRUG DELIVERY REVIEWS

How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

(2014) Gloria Wong et al.   BMC INFECTIOUS DISEASES

Determination of meropenem in bacterial media by LC–MS/MS

(2014) Liusheng Huang et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Surviving Sepsis Campaign

(2013) R. Phillip Dellinger et al.   CRITICAL CARE MEDICINE

HPLC Method for Measuring Meropenem and Biapenem Concentrations in Human Peritoneal Fluid and Bile: Application to Comparative Pharmacokinetic Investigations

(2013) K. Kameda et al.   JOURNAL OF CHROMATOGRAPHIC SCIENCE

β-Lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review

(2012) Mahipal G Sinnollareddy et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy

(2012) Darren M. Roberts et al.   CRITICAL CARE MEDICINE

Notice

(2012)   Kidney International Supplements